Biased Signaling in G Protein-Coupled Receptors: Understanding the Biological Relevance and Tools for Probing...

Area of Science:

• Pharmacology
• Molecular Biology
• Drug Discovery

Background:

• Receptors, especially G protein-coupled receptors (GPCRs), exhibit biased signaling, activating specific intracellular pathways selectively.
• This phenomenon allows for the development of targeted therapeutics with minimized side effects by precisely modulating receptor activity.
• GPCRs are crucial pharmacological targets, with approximately one-third of FDA-approved drugs acting upon them.

Purpose of the Study:

• To explore the mechanisms and complexities of GPCR signaling through biased signaling.
• To highlight the role of functionally selective ligands in understanding receptor function.
• To discuss the implications of biased signaling for therapeutic innovation.

Main Methods:

• Utilizing functionally selective ligands to probe distinct signaling branches of GPCRs.
• Leveraging advancements in biosensor development and multiplex assay platforms.
• Employing deep mutational scanning methods to define GPCR signaling pathways.

Main Results:

• Biased signaling provides a framework for understanding how GPCRs activate specific intracellular pathways.
• Functionally selective ligands are instrumental in dissecting the nuances of GPCR signaling.
• Advancements in technology are enhancing the ability to characterize biased signaling pathways.

Conclusions:

• Biased signaling has revolutionized pharmacology by enabling targeted therapeutic strategies.
• Understanding GPCR biased signaling is critical for developing next-generation medicines.
• Continued research in this area promises significant therapeutic advancements.